亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯(lián)系方式|購物車
企業(yè)會員第1年

合肥賽曼諾生物科技有限公司  

肽核酸,類肽和多肽定制合成服務(wù)以及肽核酸單體,類肽單體

搜索
網(wǎng)站公告
合肥賽曼諾生物科技有限公司是專注于固相合成方法學研究的專業(yè)化高科技公司。賽曼諾具有多年的固相合成研究開發(fā)生產(chǎn)經(jīng)驗。賽曼諾致力于為全球范圍內(nèi)的客戶提供包括肽核酸,類肽和多肽定制合成服務(wù)以及肽核酸單體,類肽單體。
新聞中心
產(chǎn)品分類
  • 暫無分類
聯(lián)系方式
  • 聯(lián)系人:周沐
  • 電話:0551-65326643
  • 郵件:info@cellmano.com
  • QQ:1761863581
站內(nèi)搜索
 
榮譽資質(zhì)
  • 暫未上傳
友情鏈接
  • 暫無鏈接
  供應(yīng)產(chǎn)品
Antho-Rnamide 面議0詢價
L-Anserine · nitrate 面議0詢價
ELH (Aplysia california) 面議0詢價
C-ANF (4-23) 面議0詢價
H-Ala-Ala-Ala-OH 面議0詢價
Alytesin 面議0詢價
(Thr6)-Bradykinin 面議0詢價
Angiotensin I/II (3-7) 面議0詢價
Angiotensin I/II (3-8) 面議0詢價
Angiotensin I/II (4-8) 面議0詢價
Angiotensin I/II (5-8) 面議0詢價
©2025 合肥賽曼諾生物科技有限公司 版權(quán)所有   技術(shù)支持:化工網(wǎng)   訪問量:7656  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |